122 related articles for article (PubMed ID: 35830714)
1. The tumour/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: a correlation study between the Nrf2 and KRas pathways.
Chang LC; Fan CW; Tseng WK; Chen JR; Hua CC
Biomarkers; 2022 Nov; 27(7):701-707. PubMed ID: 35830714
[TBL] [Abstract][Full Text] [Related]
2. The level of S-glutathionylated protein is a predictor for metastasis in colorectal cancer and correlated with those of Nrf2/Keap1 pathway.
Chang LC; Fan CW; Tseng WK; Hua CC
Biomarkers; 2021 Dec; 26(8):780-787. PubMed ID: 34704878
[TBL] [Abstract][Full Text] [Related]
3. Associations between the Nrf2/Keap1 pathway and mitochondrial functions in colorectal cancer are affected by metastasis.
Chang LC; Fan CW; Tseng WK; Hua CC
Cancer Biomark; 2020; 27(2):163-171. PubMed ID: 31796664
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of the Nrf2 pathway in colorectal cancer: Nrf2 expression is closely correlated to Keap1 in the tumor and Bach1 in the normal tissue.
Chang LC; Fan CW; Tseng WK; Chen JR; Chein HP; Hwang CC; Hua CC
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):511-7. PubMed ID: 23455180
[TBL] [Abstract][Full Text] [Related]
5. Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.
Sadeghi MR; Jeddi F; Soozangar N; Somi MH; Shirmohamadi M; Khaze V; Samadi N
Biomed Pharmacother; 2018 Aug; 104():458-464. PubMed ID: 29793178
[TBL] [Abstract][Full Text] [Related]
6. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
7. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer.
Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
Biomark Med; 2017 Dec; 11(12):1103-1111. PubMed ID: 29053012
[TBL] [Abstract][Full Text] [Related]
8. The Ratio of Hmox1/Nrf2 mRNA Level in the Tumor Tissue Is a Predictor of Distant Metastasis in Colorectal Cancer.
Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
Dis Markers; 2016; 2016():8143465. PubMed ID: 27999449
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
[TBL] [Abstract][Full Text] [Related]
10. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
Li C; Wu H; Wang S; Zhu J
Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma.
Huang CF; Zhang L; Ma SR; Zhao ZL; Wang WM; He KF; Zhao YF; Zhang WF; Liu B; Sun ZJ
PLoS One; 2013; 8(12):e83479. PubMed ID: 24386210
[TBL] [Abstract][Full Text] [Related]
12. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer.
Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease.
To K; Okada K; Watahiki T; Suzuki H; Tsuchiya K; Tokushige K; Yamamoto M; Ariizumi SI; Shoda J
Cancer Med; 2023 Oct; 12(19):19423-19437. PubMed ID: 37732511
[TBL] [Abstract][Full Text] [Related]
16. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
17. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
[TBL] [Abstract][Full Text] [Related]
18. The Keap1-Nrf2 System: A Mediator between Oxidative Stress and Aging.
Yu C; Xiao JH
Oxid Med Cell Longev; 2021; 2021():6635460. PubMed ID: 34012501
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
[TBL] [Abstract][Full Text] [Related]
20. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
